Search

everythinglearnresearchcommunity

for

Search:↓

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Cuscuta reflexa extracts helped regrow hair in rats with drug-induced hair loss.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

Topical 5-Fluorouracil can rarely cause nerve damage, especially in people with a certain genetic deficiency.

Radiotherapy can cause rare changes in hair color, which should be discussed with patients.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Many men with androgenic alopecia also have dyslipidemia.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

CHOP chemotherapy causes many side effects but is generally well tolerated.

Dermoscopy can help assess the severity of chronic radiation-induced skin damage in head and neck cancer patients.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

The document is a detailed medical reference on skin and genetic disorders.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

PGA-4HGF may help treat hair loss by activating hair growth pathways and extending the hair growth phase.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

Ayurveda, using herbs like ginger, garlic, and turmeric, can reduce chemo-radiotherapy side effects in cancer patients.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.